Cargando…

HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway

Chemoresistance remains as a major hindrance in the treatment of hepatocellular carcinoma (HCC). High mobility group box protein 1 (HMGB1) enhances autophagic flux and protects tumor cells from apoptosis, which results in acquired drug resistance. However, the exact mechanisms underlying HMGB1-modul...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Junhua, Zhou, Wei, Mao, Qiang, Gao, Dandan, Xiong, Lin, Hu, Xinyao, Zheng, Yongfa, Xu, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578906/
https://www.ncbi.nlm.nih.gov/pubmed/34778055
http://dx.doi.org/10.3389/fonc.2021.739145
_version_ 1784596335061630976
author Li, Junhua
Zhou, Wei
Mao, Qiang
Gao, Dandan
Xiong, Lin
Hu, Xinyao
Zheng, Yongfa
Xu, Ximing
author_facet Li, Junhua
Zhou, Wei
Mao, Qiang
Gao, Dandan
Xiong, Lin
Hu, Xinyao
Zheng, Yongfa
Xu, Ximing
author_sort Li, Junhua
collection PubMed
description Chemoresistance remains as a major hindrance in the treatment of hepatocellular carcinoma (HCC). High mobility group box protein 1 (HMGB1) enhances autophagic flux and protects tumor cells from apoptosis, which results in acquired drug resistance. However, the exact mechanisms underlying HMGB1-modulated autophagy in HCC chemoresistance remain to be defined. In the present study, we found that administration of doxorubicin (DOX) significantly promoted HMGB1 expression and induced HMGB1 cytoplasmic translocation in human HCC cell lines BEL7402 and SMMC7721, which enhanced autophagy that contributes to protecting HCC cells from apoptosis and increasing drug resistance. Moreover, we observed HMGB1 translocation and elevation of autophagy in DOX-resistant BEL7402 and SMMC7721 cells. Additionally, inhibition of HMGB1 and autophagy increased the sensitivities of BEL-7402 and SMMC-7721 cells to DOX and re-sensitized their DOX-resistant cells. Subsequently, we confirmed with HMGB1 regulated autophagy by activating the 5ʹ adenosine monophosphate-activated protein kinase (AMPK)/mTOR pathway. In summary, our results indicate that HMGB1 promotes acquired DOX resistance in DOX-treated BEL7402 and SMMC7721 cells by enhancing autophagy through the AMPK/mTOR signaling pathway. These findings provide the proof-of-concept that HMGB1 inhibitors might be an important targeted treatment strategy for HCC.
format Online
Article
Text
id pubmed-8578906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85789062021-11-11 HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway Li, Junhua Zhou, Wei Mao, Qiang Gao, Dandan Xiong, Lin Hu, Xinyao Zheng, Yongfa Xu, Ximing Front Oncol Oncology Chemoresistance remains as a major hindrance in the treatment of hepatocellular carcinoma (HCC). High mobility group box protein 1 (HMGB1) enhances autophagic flux and protects tumor cells from apoptosis, which results in acquired drug resistance. However, the exact mechanisms underlying HMGB1-modulated autophagy in HCC chemoresistance remain to be defined. In the present study, we found that administration of doxorubicin (DOX) significantly promoted HMGB1 expression and induced HMGB1 cytoplasmic translocation in human HCC cell lines BEL7402 and SMMC7721, which enhanced autophagy that contributes to protecting HCC cells from apoptosis and increasing drug resistance. Moreover, we observed HMGB1 translocation and elevation of autophagy in DOX-resistant BEL7402 and SMMC7721 cells. Additionally, inhibition of HMGB1 and autophagy increased the sensitivities of BEL-7402 and SMMC-7721 cells to DOX and re-sensitized their DOX-resistant cells. Subsequently, we confirmed with HMGB1 regulated autophagy by activating the 5ʹ adenosine monophosphate-activated protein kinase (AMPK)/mTOR pathway. In summary, our results indicate that HMGB1 promotes acquired DOX resistance in DOX-treated BEL7402 and SMMC7721 cells by enhancing autophagy through the AMPK/mTOR signaling pathway. These findings provide the proof-of-concept that HMGB1 inhibitors might be an important targeted treatment strategy for HCC. Frontiers Media S.A. 2021-10-27 /pmc/articles/PMC8578906/ /pubmed/34778055 http://dx.doi.org/10.3389/fonc.2021.739145 Text en Copyright © 2021 Li, Zhou, Mao, Gao, Xiong, Hu, Zheng and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Junhua
Zhou, Wei
Mao, Qiang
Gao, Dandan
Xiong, Lin
Hu, Xinyao
Zheng, Yongfa
Xu, Ximing
HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
title HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
title_full HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
title_fullStr HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
title_full_unstemmed HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
title_short HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
title_sort hmgb1 promotes resistance to doxorubicin in human hepatocellular carcinoma cells by inducing autophagy via the ampk/mtor signaling pathway
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578906/
https://www.ncbi.nlm.nih.gov/pubmed/34778055
http://dx.doi.org/10.3389/fonc.2021.739145
work_keys_str_mv AT lijunhua hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway
AT zhouwei hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway
AT maoqiang hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway
AT gaodandan hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway
AT xionglin hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway
AT huxinyao hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway
AT zhengyongfa hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway
AT xuximing hmgb1promotesresistancetodoxorubicininhumanhepatocellularcarcinomacellsbyinducingautophagyviatheampkmtorsignalingpathway